ZEUS ELISA Parvovirus B19 IgG Test System, Product Number SM9Z7701M
FDA Device Recall #Z-0602-2024 — Class II — October 31, 2023
Recall Summary
| Recall Number | Z-0602-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 31, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Zeus Scientific, Inc. |
| Location | Branchburg, NJ |
| Product Type | Devices |
| Quantity | 296 kits |
Product Description
ZEUS ELISA Parvovirus B19 IgG Test System, Product Number SM9Z7701M
Reason for Recall
The organization completed a product improvement process to the conjugate found within the certain ELISA kits. This modification was not reviewed and approved by FDA prior to its implementation.
Distribution Pattern
US States: CA, MA, MI, NJ, NY, TN, UT.
Lot / Code Information
UDI: (01)00845533001748(17)240731(10)23030068 (01)00845533001755(17)241130(10)23060217 (01)00845533001779(17)241130(10)23060218; Lot Numbers: 23030068 23060217 23060218
Other Recalls from Zeus Scientific, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0603-2024 | Class II | ZEUS ELISA Parvovirus B19 IgM Test System, Prod... | Oct 31, 2023 |
| Z-3026-2020 | Class II | ZEUS ELISA Parvovirus B19 IgM Test System, UDI ... | Aug 12, 2019 |
| Z-2494-2019 | Class II | Dynex DSX Software-IVD ELISA Assays effected a... | Jul 22, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.